Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Total Debt/Equity

    Back to All Ratios
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Total Debt/Equity(x) 2.051.802.092.261.85

What is the latest Total Debt/Equity ratio of BAL PHARMA ?

The latest Total Debt/Equity ratio of BAL PHARMA is 2.05 based on Mar2023 Consolidated results.
Year Total Debt/Equity
Mar20232.05
Mar20221.80
Mar20212.09
Mar20202.26
Mar20191.85

How is Total Debt/Equity of BAL PHARMA Trending?

Years Total Debt/Equity % Change
Mar2023 2.05
13.89
Mar2022 1.8
-13.88
Mar2021 2.09
-7.52
Mar2020 2.26
22.16
Mar2019 1.85 -

Other Financial Ratios of BAL PHARMA


Compare Total Debt/Equity ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹155.8 Cr -1.7% -4.7% 23.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹358,305.0 Cr -1% -7.2% 56.8% Stock Analytics
CIPLA ₹109,709.0 Cr -4.6% -6.2% 49.8% Stock Analytics
DIVIS LABORATORIES ₹100,599.0 Cr -4.1% 1.1% 19.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,073.3 Cr -7.4% -4.8% 22.7% Stock Analytics
ZYDUS LIFESCIENCES ₹97,383.3 Cr -2.9% -3.9% 94.8% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-1.7%

-4.7%

23.7%

SENSEX

-3%

-2.5%

17.3%


You may also like the below Video Courses